NEI Research News

An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.

Researchers at the University of Virginia have successfully treated age-related macular degeneration (AMD) in mice after finding an unexpected link between the two main forms of the blinding eye disease.

In a new study from Virginia Tech, neuroscientists reveal a surprising clue about how the intricate visual processing system forms during early brain development.

A new study from Brown researchers finds that rewards improve performance on a visual perceptual task only if participants sleep after training.

Researchers at the University of South Florida have discovered a novel feedback pathway from the brain to the eye that modulates eye pressure – a significant advancement in the effort to diagnose and treat glaucoma.

Study from Columbia University uncovers human-like brain circuit at work. Their findings lay the groundwork for mapping mechanisms of color vision.

Researchers at the University of New Hampshire have reported the first structural model for a key enzyme, and its activating protein, that can play a role in some genetically inherited eye diseases like retinitis pigmentosa and night blindness.

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.

Researchers at the Picower Institute at MIT have discovered cellular mechanisms behind amblyopia and visual memory.

LSU researchers have discovered unique patterns of genetic activity that may lead to the development of blinding retinal diseases.